期刊文献+

健脾益肺方治疗吞咽障碍肌萎缩侧索硬化疗效观察 被引量:7

Observation of Jianpiyifei Decoction on Muscular Atrophy and Lateral Sclerosis in Dysphagia
下载PDF
导出
摘要 目的观察健脾益肺方治疗吞咽障碍肌萎缩侧索硬化(ALS)的临床疗效。方法对肺脾两虚的20例吞咽障碍肌萎缩侧索硬化患者予服自拟健脾益肺方,疗程20周,应用洼田饮水试验、ALSSS量表吞咽部分及ALSFRS-R量表进行治疗前后疗效评价,并观察不良反应。结果治疗后,患者洼田饮水试验、ALSSS量表吞咽部分及ALSFRS-R量表积分均较治疗前明显改善,ALSFRS-R量表每月下降值总体呈减小趋势。结论初步研究表明健脾益肺方治疗肌萎缩侧索硬化安全,可在一定程度上对ALS患者言语、流涎、吞咽等延髓症状及部分运动功能进展速度。 Objective: To observe the effect of Jianpiyifei Decoction on muscular atrophy and lateral sclerosis in dysphagia.Methods: 20 deficiency of spleen and lung cases with muscular atrophy and lateral sclerosis in dysphagia were used the Jianpiyifei Decoction.After 20 weeks,the clinical effects were evaluated by the water-swallowing test,the swallowing part of ALSSS test and the ALSFRS-R test.Meanwhile,the adverse reactions also were observed.Results: After treatment,the scores were improved obviously in above tests.There was the decreasing tendency in the reduction value about the ALSFRS-R test.Conclusion: Jianpiyifei Decoction,by which the language,the salivation,the swallow and the motion are improved,is safe and effective in the muscular atrophy and lateral sclerosis in dysphagia,
出处 《中国中医急症》 2012年第7期1123-1124,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 2010年广东省科技计划项目(2010B030700027) 2009年广州中医药大学中医药科研创新基金项目(09CX074)
关键词 肌萎缩侧索硬化 健脾益肺方 吞咽障碍 Muscular atrophy and lateral sclerosis in dysphagia Jianpiyifei Decoction Swallow dysfunction
  • 相关文献

参考文献12

  • 1Andersena PM ,Borasiob GD, Dengler R,et al. EFNS task force on management of amyotrophic lateral sclerosis:guidelines for diagnosing and clinical care of patients and relatives[J]. European Journal of Neurology, 2005,12 (4) : 921-938. 被引量:1
  • 2Brooks BR, Miller RG, Swash M, et al. E 1 Escorial revisited :revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].Amyotroph Lateral Scler Other Motor Neuron Disord ,2000,1 (4) :293-299. 被引量:1
  • 3Marc Riviere,Vincent Meininger,Phillipe Zeisser.An analysis of ex- tended survival in patients with amyotrophic lateral sclerosis treated with riluzole [J ]. Arch Neurol, 1998,55 (12) : 526-528. 被引量:1
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119. 被引量:985
  • 5Auzou P. Clinical assessment of dysarthria :presentation and validation of amethod [ J ]. RevN eurol (Paris), 1998,154 (4) : 523-530. 被引量:1
  • 6Hillel AD ,Miller RM ,Yorkston K,et al. Amyotrophic lateral sclerosis severity scale [J ]. Neuroepidemiology, 1989,8 (5) : 142-150. 被引量:1
  • 7Kaufmann P, Levy G, Thompson JLP, et al. The ALSFRS-R predicts survival time in an ALS clinic population [J ]. Neurology, 2005,64 ( 11 ) : 38-43. 被引量:1
  • 8Katja Kollewe, Ulrike Mauss, Klaus Krampfl. ALSFRS-R score and its ratio :A useful predictor for ALS-progression[J]. Neurol Sci,2008, 275 (6) :69-73. 被引量:1
  • 9郭帆,董梦久.运动神经元病的中医病因病机探讨[J].长春中医药大学学报,2007,23(4):3-4. 被引量:12
  • 10任一军,赵白玉.耳鼻咽喉疾病从脾胃论治──干祖望学术思想介绍[J].中医药研究,1994,10(1):5-6. 被引量:6

二级参考文献4

共引文献1002

同被引文献69

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部